| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |